UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 93

Sortiert nach

Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains

Molecular psychiatry, 2023-03, Vol.28 (3), p.1272-1283

2023

Volltextzugriff (PDF)

Tau PET imaging in neurodegenerative tauopathies-still a challenge

Molecular psychiatry, 2019-08, Vol.24 (8), p.1112-1134

2019

Volltextzugriff (PDF)

Tau PET imaging in neurodegenerative tauopathies—still a challenge

Molecular psychiatry, 2019-08, Vol.24 (8), p.1112-1134

2019

Volltextzugriff (PDF)

[18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging

European journal of nuclear medicine and molecular imaging, 2010-03, Vol.37 (3), p.594-605

2010

Volltextzugriff (PDF)

Astroglial tracer BU99008 detects multiple binding sites in Alzheimer's disease brain

Molecular psychiatry, 2021-10, Vol.26 (10), p.5833-5847

2021

Volltextzugriff (PDF)

Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases

European journal of nuclear medicine and molecular imaging, 2021-04, Vol.48 (4), p.1093-1102

2021

Volltextzugriff (PDF)

Looking for a 5-HT7 radiotracer for positron emission tomography

Bioorganic & medicinal chemistry letters, 2010-06, Vol.20 (12), p.3730-3733

2010

Volltextzugriff (PDF)

Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer's disease variants: AβPParc and PSEN1DE9

Molecular psychiatry, 2021-10, Vol.26 (10), p.5609-5619

2021

Volltextzugriff (PDF)

Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging

The Journal of nuclear medicine (1978), 2012-06, Vol.53 (6), p.969-976

2012

Volltextzugriff (PDF)

Tau positron emission tomography imaging in tauopathies: The added hurdle of off-target binding

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2018, Vol.10 (1), p.232-236

2018

Volltextzugriff (PDF)

Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains

Alzheimer's research & therapy, 2017-12, Vol.9 (1), p.96-96, Article 96

2017

Volltextzugriff (PDF)

Lack of fibrillar amyloid plaques but hypometabolism and astrogliosis in autosomal dominant variant AßPParc Alzheimer's disease

Molecular psychiatry, 2021-10, Vol.26 (10), p.5471-5471

2021

Volltextzugriff (PDF)

Synthesis and biological evaluation in rat and cat of [18 F]12ST05 as a potential 5-HT6 PET radioligand

Nuclear medicine and biology, 2007-11, Vol.34 (8), p.995-1002

2007

Volltextzugriff (PDF)

Correction: Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains

Molecular psychiatry, 2024-01, Vol.29 (1), p.38-38

2024

Volltextzugriff (PDF)

Development of [11 C]/[3 H]THK-5351 – A Potential Novel Carbon-11 Tau Imaging PET Radioligand

Nuclear medicine and biology, 2017-03, Vol.46, p.50-53

2017

Volltextzugriff (PDF)

Tau PET imaging: present and future directions

Molecular neurodegeneration, 2017-02, Vol.12 (1), p.19-19, Article 19

2017

Volltextzugriff (PDF)

Radiosynthesis and Preclinical Evaluation of 18 F-F13714 as a Fluorinated 5-HT 1A Receptor Agonist Radioligand for PET Neuroimaging

Journal of Nuclear Medicine, 2012-06, Vol.53 (6), p.969-976

2012

Volltextzugriff (PDF)

Radiosynthesis and Preclinical Evaluation of ^sup 18^F-F13714 as a Fluorinated 5-HT^sub 1A^ Receptor Agonist Radioligand for PET Neuroimaging

The Journal of nuclear medicine (1978), 2012-06, Vol.53 (6), p.969

2012

Volltextzugriff (PDF)

Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imaging

European journal of nuclear medicine and molecular imaging, 2019-06, Vol.46 (6), p.1369-1382

2019

Volltextzugriff (PDF)

Cortical laminar tau deposits and activated astrocytes in Alzheimer's disease visualised by 3 H-THK5117 and 3 H-deprenyl autoradiography

Scientific reports, 2017-04, Vol.7, p.45496

2017

Volltextzugriff (PDF)

Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer's disease variants: A[beta]PParc and PSEN1DE9

Molecular psychiatry, 2021-10, Vol.26 (10), p.5609

2021

Volltextzugriff (PDF)

Lack of fibrillar amyloid plaques but hypometabolism and astrogliosis in autosomal dominant variant A[beta]PParc Alzheimer's disease

Molecular psychiatry, 2021-10, Vol.26 (10), p.5471

2021

Volltextzugriff (PDF)

Cortical laminar tau deposits and activated astrocytes in Alzheimer’s disease visualised by 3H-THK5117 and 3H-deprenyl autoradiography

Scientific reports, 2017-04, Vol.7 (1), p.45496-45496, Article 45496

2017

Volltextzugriff (PDF)

Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease

European journal of nuclear medicine and molecular imaging, 2019-05, Vol.46 (5), p.1152-1163

2019

Volltextzugriff (PDF)

VISUALIZING BRAIN ASTROCYTES - CHARACTERIZATION OF 3H-BU99008, AN IMIDAZOLINE 2 RECEPTOR LIGAND, IN THE HUMAN AD BRAIN

Alzheimer's & dementia, 2019-07, Vol.15 (7), p.P543-P543

2019

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(91)

Publikationsform

Artikel
(93)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(39)
Life Sciences & Biomedicine
(34)
Humans
(21)
Medicin Och Hälsovetenskap
(19)
Alzheimer's Disease
(17)
Autoradiography
(17)
Male
(16)
Animals
(14)
Brain - Metabolism
(13)
Neurosciences
(12)
Neurosciences & Neurology
(12)
Female
(11)
Binding Sites
(9)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Pet
(9)
Positron-Emission Tomography - Methods
(9)
Rats
(9)
Brain - Diagnostic Imaging
(8)
Neurodegenerative Diseases
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains

Tau PET imaging in neurodegenerative tauopathies-still a challenge

Tau PET imaging in neurodegenerative tauopathies—still a challenge

[18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging

Astroglial tracer BU99008 detects multiple binding sites in Alzheimer's disease brain

Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases

Looking for a 5-HT7 radiotracer for positron emission tomography

Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer's disease variants: AβPParc and PSEN1DE9

Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging

Tau positron emission tomography imaging in tauopathies: The added hurdle of off-target binding

Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains

Lack of fibrillar amyloid plaques but hypometabolism and astrogliosis in autosomal dominant variant AßPParc Alzheimer's disease

Synthesis and biological evaluation in rat and cat of [18 F]12ST05 as a potential 5-HT6 PET radioligand

Correction: Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains

Development of [11 C]/[3 H]THK-5351 – A Potential Novel Carbon-11 Tau Imaging PET Radioligand

Tau PET imaging: present and future directions

Radiosynthesis and Preclinical Evaluation of 18 F-F13714 as a Fluorinated 5-HT 1A Receptor Agonist Radioligand for PET Neuroimaging

Radiosynthesis and Preclinical Evaluation of ^sup 18^F-F13714 as a Fluorinated 5-HT^sub 1A^ Receptor Agonist Radioligand for PET Neuroimaging

Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imaging

Cortical laminar tau deposits and activated astrocytes in Alzheimer's disease visualised by 3 H-THK5117 and 3 H-deprenyl autoradiography

Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer's disease variants: A[beta]PParc and PSEN1DE9

Lack of fibrillar amyloid plaques but hypometabolism and astrogliosis in autosomal dominant variant A[beta]PParc Alzheimer's disease

Cortical laminar tau deposits and activated astrocytes in Alzheimer’s disease visualised by 3H-THK5117 and 3H-deprenyl autoradiography

Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease

VISUALIZING BRAIN ASTROCYTES - CHARACTERIZATION OF 3H-BU99008, AN IMIDAZOLINE 2 RECEPTOR LIGAND, IN THE HUMAN AD BRAIN

Suchergebnisse filtern